Literature DB >> 8263752

Endocrine function in the HIV wasting syndrome.

G O Coodley1, M O Loveless, H D Nelson, M K Coodley.   

Abstract

We compared endocrine function in patients with the HIV wasting syndrome with other HIV-positive patients without wasting to determine associations between endocrine dysfunction and wasting. Sixty-six HIV-seropositive patients were evaluated by thyroid, gonadal, and adrenal function tests. Fourteen of these patients met the clinical definition of wasting. Total and free testosterone levels were significantly lower in patients with wasting compared with patients without wasting with both similar and higher mean CD4 counts. Prolactin levels were significantly higher, and cortisol levels were higher with borderline significance in patients with wasting compared with patients with similar CD4 counts without wasting. These findings suggest that endocrine function in the HIV wasting syndrome differs from that of HIV-infected patients without wasting, which may have implications about the pathogenesis and treatment of the HIV wasting syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8263752

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  11 in total

1.  Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settings.

Authors:  Hartmut Stocker; Charlotte Kloft; Nele Plock; Antje Breske; Guido Kruse; Christian Herzmann; Hubert Schulbin; Peter Kreckel; Christoph Weber; Frank Goebel; Joerg Roeling; Schlomo Staszewski; Andreas Plettenberg; Christiane Moecklinghoff; Keikawus Arastéh; Michael Kurowski
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania.

Authors:  Gretchen Antelman; Sylvia Kaaya; Ruilan Wei; Jessie Mbwambo; Gernard I Msamanga; Wafaie W Fawzi; Mary C Smith Fawzi
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-01       Impact factor: 3.731

Review 3.  Potential therapeutics of vitamin E (tocopherol) in AIDS and HIV.

Authors:  Y Wang; R R Watson
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

4.  Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.

Authors:  S Bhasin; T W Storer; M Javanbakht; N Berman; K E Yarasheski; J Phillips; M Dike; I Sinha-Hikim; R Shen; R D Hays; G Beall
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

Review 5.  Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging.

Authors:  Shalender Bhasin; Olga M Calof; Thomas W Storer; Martin L Lee; Norman A Mazer; Ravi Jasuja; Victor M Montori; Wenqing Gao; James T Dalton
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-03

Review 6.  Neuroimmune mechanisms in health and disease: 2. Disease.

Authors:  H Anisman; M G Baines; I Berczi; C N Bernstein; M G Blennerhassett; R M Gorczynski; A H Greenberg; F T Kisil; R D Mathison; E Nagy; D M Nance; M H Perdue; D K Pomerantz; E R Sabbadini; A Stanisz; R J Warrington
Journal:  CMAJ       Date:  1996-10-15       Impact factor: 8.262

7.  Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV.

Authors:  Musie Ghebremichael; Elijah Paintsil; Jeannette R Ickovics; David Vlahov; Paula Schuman; Robert Boland; Ellie Schoenbaum; Janet Moore; Heping Zhang
Journal:  AIDS Care       Date:  2009-07

Review 8.  Therapeutic options for HIV-associated bodyweight loss. A risk-benefit analysis.

Authors:  V Stosor; J V Roenn
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

9.  Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997.

Authors:  E Malvy; R Thiébaut; C Marimoutou; F Dabis
Journal:  J Am Coll Nutr       Date:  2001-12       Impact factor: 3.169

Review 10.  Neuromuscular complications in HIV: effects of aging.

Authors:  Jessica Robinson-Papp; Ik Lin Tan; David M Simpson
Journal:  J Neurovirol       Date:  2011-12-30       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.